Truist Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Truist Financial’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$150K	Buy	+35,529	New	+$137K	﹤0.01%	2821

Other funds holding IRWD

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Truist Financial's IRWD Position: Q2 2026 in Review

Truist Financial opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2026: 35,529 shares worth $150K. The stake represents ﹤0.01% of the portfolio and ranks #2821 among its holdings.

36 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Truist Financial held 35,529 shares of Ironwood Pharmaceuticals worth $150K as of Q2 2026.
Ironwood Pharmaceuticals was a new Truist Financial position in Q2 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2821 holding.
36 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.